Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2026

Annual patent cliff calendar for 2026 — US pharmaceutical patents by expiration date.

Patents
353

Quick answer

353 indexed pharmaceutical patents have expiration dates in 2026. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7112338

    Cationic liposome delivery of taxanes to angiogenic blood vessels

    The Regents of the University of California · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7112566

    Systemic administration of Hypocretin-1

    The Regents of the University of California · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7112415

    Method of preparing cell cultures from biological specimens for assaying a response to an agent

    Precision Therapeutics, Inc. · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7112574

    C2,8-disubstituted adenosine derivatives and their different uses

    CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7112342

    Enriched platelet wound healant

    Cytomedix, Inc. · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7112442

    Peptides for gene delivery

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7112341

    Pulmonary administration of dry powder formulations for treating infertility

    Nektar Therapeutics · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7112332

    Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

    The United States of America as represented by the Secretary of the Army · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7115590

    Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents

    University College Cardiff Consultants Limited · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7115746

    Processes for the facile synthesis of diaryl amines and analogues thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7115728

    Human peroxisome proliferator activated receptor γ

    Ligand Pharmaceuticals Incorporated · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7115739

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7115360

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7115405

    Hyaluronan synthase gene and uses thereof

    The Board of Regents of the University of Oklahoma · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7115262

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7115577

    Colorectal neoplasia prophylaxis

    The Board of Regents of the University of Texas System · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7115260

    Interleukin-1β converting enzyme like apoptotic protease-6

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7115280

    Particle formation methods and their products

    Nektar Therapeutics UK, Ltd · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7115560

    Methods for modulating gastric secretion using prokineticin receptor antagonists

    The Regents of the University of California · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7115582

    HoxD3 and HoxA3 compositions and methods for improved wound healing

    The Regents of the University of California · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7119066

    Modified ciliary neurotrophic factor (CNTF)

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7118746

    Conditioned cell culture medium compositions and methods of use

    SkinMedica, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7118747

    AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

    Pacific Northwest Biotechnology Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7118873

    Polynucleotides encoding cellular transporters and methods of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7118758

    Transformed bacteria producing CS6 antigens as vaccines

    The United States of America as represented by the Secretary of the Army · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7118865

    Methods for diagnosing severe systemic lupus erythematosus

    Regents of the University of Minnesota · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7119103

    β3-Adrenoreceptor agonists, agonist compositions and methods of using

    Molecular Design International, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7119200

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7119105

    Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

    The Regents of the University of California · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7119221

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7119064

    Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

    The Board of Regents of the University of Texas System · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7118738

    Recombinant pox virus for immunization against MUC1 tumor-associated antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7118752

    Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7118919

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7119223

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7122200

    Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7122558

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall Prodesfarma S.A. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7122714

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7122681

    Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7122624

    Parathyroid hormone receptor ligands

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7122572

    Calixpyrroles

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7122542

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7122579

    Eye treatments using synthetic thyroid hormone compositions

    The Regents of the University of California · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7122552

    Inhibitors of JAK and CDK2 protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7122214

    Drynaria extractions for treating osteoporosis and their extraction process

    Xiyuan Hospital Affiliated to China Academy of TCM. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7125892

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2026?

353 published patents in our USPTO index have expiration dates falling in calendar year 2026.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.